Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Κύριοι συγγραφείς: Macarena Orejudo (Συγγραφέας), Raul R. Rodrigues-Diez (Συγγραφέας), Raquel Rodrigues-Diez (Συγγραφέας), Ana Garcia-Redondo (Συγγραφέας), Laura Santos-Sánchez (Συγγραφέας), Javier Rández-Garbayo (Συγγραφέας), Pablo Cannata-Ortiz (Συγγραφέας), Adrian M. Ramos (Συγγραφέας), Alberto Ortiz (Συγγραφέας), Rafael Selgas (Συγγραφέας), Sergio Mezzano (Συγγραφέας), Carolina Lavoz (Συγγραφέας), Marta Ruiz-Ortega (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...